$0.15 SPMXF Supermax Corporation Berhad PNK 24 Feb 2026: oversold, watch bounce
SPMXF stock is trading at $0.15 on the PNK exchange in the United States during market hours, setting up a classic oversold bounce opportunity. Volume is 3,485 versus an average volume of 847, giving a relative volume of 4.12 that signals short-term trader interest. The company, Supermax Corporation Berhad, shows a low price range this year between $0.15 and $0.18, while earnings per share are -0.01 and PE reads -15.00. For traders focused on oversold bounces, this price, liquidity spike, and sector backdrop merit a measured trading plan.
SPMXF stock quick snapshot
SPMXF stock trades at $0.15 (PNK, United States) with a day low of $0.15 and day high of $0.18. Market cap is 458588074.00 USD and shares outstanding are 3057253824.00, giving clear microcap/OTC dynamics that amplify moves. Volume today is 3,485.00 against an average of 847.00, so intraday volatility is elevated and sets the stage for a short-term bounce trade.
SPMXF stock fundamentals and valuation
Supermax Corporation Berhad reports EPS of -0.01 and a PE of -15.00, while price-to-book is 0.46, indicating the market values the company below book on a USD basis. Key balance metrics show cash per share 0.28 and book value per share 1.28, and a current ratio of 3.75, which supports short-term liquidity. See the company site for filings and corporate updates: Supermax website.
SPMXF stock technicals and oversold bounce setup
Price sits at the lower bound of its 52-week range ($0.15), which often triggers mean-reversion bounces in thinly traded OTC names. The sharp spike in relative volume (4.12) with a low base price increases the chance of a short-term reversal; traders should watch intraday liquidity and place tight stops. Technical indicators are muted in the feed, but price action near $0.15 is the primary trigger for an oversold bounce strategy.
Meyka AI rates SPMXF with a score out of 100 and forecast for SPMXF stock
Meyka AI rates SPMXF with a score out of 100: 62.64 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of $0.15 and a quarterly price of $0.12, versus the current price of $0.15, implying 0.00% monthly change and -20.00% quarterly downside. Forecasts are model-based projections and not guarantees. Meyka AI provides this as part of our AI-powered market analysis platform.
Catalysts, risks and sector context for SPMXF stock
Short-term catalysts include an upcoming earnings announcement on 2026-03-03 and any trade flow into medical glove stocks driven by demand shifts. Risks are weak recent revenue growth (-21.30% YoY at last FY), negative net margin (-30.13%), and thin OTC liquidity, which can widen spreads. The stock sits in the Healthcare sector, Medical – Instruments & Supplies industry, where sector news and regulation can move prices quickly.
SPMXF stock trading strategy and price targets
For an oversold bounce strategy, consider a tight intraday plan: risk no more than 1.0%–2.0% of capital per trade, use a stop below $0.14 and target a conservative bounce to $0.20 for short-term traders. A defensive target if momentum fails is $0.12, consistent with the quarterly forecast. Position sizing should account for low liquidity and the stock’s OTC status on PNK in USD.
Final Thoughts
SPMXF stock is a thinly traded OTC name at $0.15 on PNK that currently reads as oversold with a clear short-term bounce setup because of elevated relative volume (4.12) and proximity to the 52-week low. Fundamentals show cash per share 0.28 and book value 1.28, but negative EPS (-0.01) and net margin (-30.13%) underline earnings risk. Meyka AI’s forecast model projects a monthly price of $0.15 and a quarterly price of $0.12, implying 0.00% near-term and -20.00% over the quarter; forecasts are model-based and not guarantees. Traders using an oversold bounce strategy should plan for tight risk controls, monitor earnings on 2026-03-03, and watch sector flows in healthcare supplies. For further company detail and filings, consult the Supermax website and the SPMXF quote page for live updates and liquidity notices: Supermax website and Yahoo Finance SPMXF.
FAQs
Is SPMXF stock a buy right now?
SPMXF stock shows an oversold bounce setup at $0.15, but fundamentals are mixed with EPS -0.01. Meyka AI grades SPMXF B (HOLD). Short-term traders may play a bounce with tight stops; longer-term investors should wait for earnings and clearer cash-flow recovery.
What is Meyka AI’s forecast for SPMXF stock?
Meyka AI’s forecast model projects a monthly price of $0.15 and a quarterly price of $0.12 for SPMXF stock. The quarterly figure implies -20.00% from the current $0.15. Forecasts are model-based projections and not guarantees.
What are the main risks when trading SPMXF stock?
Main risks for SPMXF stock include thin OTC liquidity, wide spreads, negative margins (-30.13%), and volatile sector news. Earnings and regulatory updates can swing price quickly, so use small position sizes and strict stops.
How can traders size positions for an oversold bounce in SPMXF stock?
For SPMXF stock, limit risk to 1.0%–2.0% of account equity per trade, set a stop below $0.14, and keep target-to-risk favorable. Factor in low volume and possible price gaps on PNK in USD.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.